- JAZZ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Jazz Pharmaceuticals (JAZZ) 10-K/A2011 FY Annual report (amended)
Filed: 27 Apr 12, 12:00am
EXHIBIT 31.4
CERTIFICATION
I, Kathryn E. Falberg, certify that:
1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals Public Limited Company (filed on behalf of and as successor to Jazz Pharmaceuticals, Inc.); and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 27, 2012 | By: | /s/ KATHRYN E. FALBERG | ||
Kathryn E. Falberg | ||||
Executive Vice President and Chief Financial Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.